Joel Greenblatt Evolus, Inc. Transaction History

Gotham Asset Management, LLC

  • $9.41 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$13.91 - $19.87 $163,066 - $232,936
-11,723 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$13.19 - $28.36 $154,626 - $332,464
11,723 New
11,723 $171,000
Q4 2018

Feb 14, 2019
SELL
$10.57 - $19.29 $135,782 - $247,799
-12,846 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$17.31 - $29.82 $222,364 - $383,067
12,846 New
12,846 $239,000

Others Institutions Holding EOLS

# of Institutions
169
Shares Held
47.8M
Call Options Held
130K
Put Options Held
51K
View Full List

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $707M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email